Bellevue Group »

Roivant Sciences Ltd Shs Isin #bmg762791017 shares owned by Bellevue Group

Quarter-by-quarter ownership of Roivant Sciences Ltd Shs Isin #bmg762791017 (ROIV) shares owned by Bellevue Group from 13F filings

Historical chart of Bellevue Group investment in Roivant Sciences Ltd Shs Isin #bmg762791017

Tip: Access up to 7 years of quarterly data

All positions including Roivant Sciences Ltd Shs Isin #bmg762791017 held by Bellevue Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Roivant Sciences Ltd Shs Isin #bmg762791017 by Bellevue Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $284k 24k 11.83

More positions owned by Bellevue Group

Ionis Pharmaceuticals (IONS)
Argenx Se Sponsored Adr (ARGX)
Revolution Medicines (RVMD)
Neurocrine Biosciences (NBIX)
Alnylam Pharmaceuticals (ALNY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abbott Laboratories (ABT)
Stryker Corporation (SYK)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Agios Pharmaceuticals (AGIO)
Incyte Corporation (INCY)
Scholar Rock Hldg Corp (SRRK)
Akero Therapeutics (AKRO)
Immunocore Hldgs Ads (IMCR)

View all positions for Bellevue Group

Top funds holding Roivant Sciences Ltd Shs Isin #bmg762791017

FMR
Morgan Stanley
Sb Investment Advisers
BlackRock
Vanguard Group
QVT Financial
Viking Global Investors
Rubric Capital Management
State Street Corporation
Two Seas Capital
Patient Square Capital
Dimensional Fund Advisors
Geode Capital Management
Perceptive Advisors
Adage Capital Partners GP

View all funds holding Roivant Sciences Ltd Shs Isin #bmg762791017